03:24 AM EDT, 04/01/2025 (MT Newswires) -- Kristen Yen, Senior Vice President, Global Clinical Operations and Patient Advocacy, on March 27, 2025, sold 95,500 shares in Soleno Therapeutics ( SLNO ) for $6,376,789. Following the Form 4 filing with the SEC, Yen has control over a total of 28,143 common shares of the company, with 28,143 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1484565/000141588925009297/xslF345X05/form4-03312025_110357.xml